154 related articles for article (PubMed ID: 30677088)
21. Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yang Y; Fan YC; Gao S; Dou CY; Zhang JJ; Sun FK; Wang K
Tohoku J Exp Med; 2014 Mar; 232(3):187-94. PubMed ID: 24646840
[TBL] [Abstract][Full Text] [Related]
22. Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines.
Jeschke J; O'Hagan HM; Zhang W; Vatapalli R; Calmon MF; Danilova L; Nelkenbrecher C; Van Neste L; Bijsmans IT; Van Engeland M; Gabrielson E; Schuebel KE; Winterpacht A; Baylin SB; Herman JG; Ahuja N
Clin Cancer Res; 2013 Jun; 19(12):3201-11. PubMed ID: 23630167
[TBL] [Abstract][Full Text] [Related]
23. A Novel Prognostic DNA Methylation Panel for Colorectal Cancer.
Chung HH; Kuo CC; Hsiao CW; Chen CY; Hu JM; Hsu CH; Chou YC; Lin YW; Shih YL
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547144
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic regulation of the novel tumor suppressor cysteine dioxygenase 1 in esophageal squamous cell carcinoma.
Kwon J; Park M; Kim JH; Lee HW; Kang MC; Park JH
Tumour Biol; 2015 Sep; 36(10):7449-56. PubMed ID: 25903467
[TBL] [Abstract][Full Text] [Related]
25. Promoter hypermethylation of cysteine dioxygenase type 1 in patients with non-small cell lung cancer.
Yin W; Wang X; Li Y; Wang B; Song M; Hulbert A; Chen C; Yu F
Oncol Lett; 2020 Jul; 20(1):967-973. PubMed ID: 32566027
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the methylation of CpG islands in the
Maekawa H; Ito T; Orita H; Kushida T; Sakurada M; Sato K; Hulbert A; Brock MV
Oncol Lett; 2020 Mar; 19(3):2197-2204. PubMed ID: 32194717
[TBL] [Abstract][Full Text] [Related]
27. Primary leiomyosarcomas of the gastrointestinal tract in the post-gastrointestinal stromal tumor era.
Aggarwal G; Sharma S; Zheng M; Reid MD; Crosby JH; Chamberlain SM; Nayak-Kapoor A; Lee JR
Ann Diagn Pathol; 2012 Dec; 16(6):532-40. PubMed ID: 22917807
[TBL] [Abstract][Full Text] [Related]
28. Targeted demethylation of the CDO1 promoter based on CRISPR system inhibits the malignant potential of breast cancer cells.
Yang J; Sun L; Liu XY; Huang C; Peng J; Zeng X; Zheng H; Cen W; Xu YX; Zhu W; Wu XY; Ling D; Zhang LL; Wei M; Liu Y; Wang D; Wang FH; Li YH; Li Q; Du Z
Clin Transl Med; 2023 Sep; 13(9):e1423. PubMed ID: 37740473
[TBL] [Abstract][Full Text] [Related]
29. ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour.
Edris B; Espinosa I; Mühlenberg T; Mikels A; Lee CH; Steigen SE; Zhu S; Montgomery KD; Lazar AJ; Lev D; Fletcher JA; Beck AH; West RB; Nusse R; van de Rijn M
J Pathol; 2012 Jun; 227(2):223-33. PubMed ID: 22294416
[TBL] [Abstract][Full Text] [Related]
30. Prospective study to validate the clinical utility of DNA diagnosis of peritoneal fluid cytology test in gastric cancer.
Harada H; Soeno T; Nishizawa N; Washio M; Sakuraya M; Ushiku H; Niihara M; Hosoda K; Kumamoto Y; Naitoh T; Sangai T; Hiki N; Yamashita K
Cancer Sci; 2021 Apr; 112(4):1644-1654. PubMed ID: 33576114
[TBL] [Abstract][Full Text] [Related]
31. Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth.
Wang Y; He T; Herman JG; Linghu E; Yang Y; Fuks F; Zhou F; Song L; Guo M
Clin Epigenetics; 2017; 9():115. PubMed ID: 29075358
[TBL] [Abstract][Full Text] [Related]
32. Promoter methylation of cysteine dioxygenase type 1: gene silencing and tumorigenesis in hepatocellular carcinoma.
Choi JI; Cho EH; Kim SB; Kim R; Kwon J; Park M; Shin HJ; Ryu HS; Park SH; Lee KH
Ann Hepatobiliary Pancreat Surg; 2017 Nov; 21(4):181-187. PubMed ID: 29264579
[TBL] [Abstract][Full Text] [Related]
33. Predictive Significance of Promoter DNA Methylation of
Kubota Y; Tanabe S; Azuma M; Horio K; Fujiyama Y; Soeno T; Furue Y; Wada T; Watanabe A; Ishido K; Katada C; Yamashita K; Koizumi W; Kusano C
J Gastric Cancer; 2021 Dec; 21(4):379-391. PubMed ID: 35079440
[TBL] [Abstract][Full Text] [Related]
34. Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3.
Booken N; Gratchev A; Utikal J; Weiss C; Yu X; Qadoumi M; Schmuth M; Sepp N; Nashan D; Rass K; Tüting T; Assaf C; Dippel E; Stadler R; Klemke CD; Goerdt S
Leukemia; 2008 Feb; 22(2):393-9. PubMed ID: 18033314
[TBL] [Abstract][Full Text] [Related]
35. Hypermethylation of the CDKN2A gene in colorectal cancer is associated with shorter survival.
Maeda K; Kawakami K; Ishida Y; Ishiguro K; Omura K; Watanabe G
Oncol Rep; 2003; 10(4):935-8. PubMed ID: 12792748
[TBL] [Abstract][Full Text] [Related]
36. Hypermethylation of the MYOD1 gene is a novel prognostic factor in patients with colorectal cancer.
Hiranuma C; Kawakami K; Oyama K; Ota N; Omura K; Watanabe G
Int J Mol Med; 2004 Mar; 13(3):413-7. PubMed ID: 14767572
[TBL] [Abstract][Full Text] [Related]
37. Novel methylation gene panel in adjacent normal tissues predicts poor prognosis of colorectal cancer in Taiwan.
Hsu CH; Hsiao CW; Sun CA; Wu WC; Yang T; Hu JM; Huang CH; Liao YC; Chen CY; Lin FH; Chou YC
World J Gastroenterol; 2020 Jan; 26(2):154-167. PubMed ID: 31988582
[TBL] [Abstract][Full Text] [Related]
38. NKX6.1 hypermethylation predicts the outcome of stage II colorectal cancer patients undergoing chemotherapy.
Chang SY; Kuo CC; Wu CC; Hsiao CW; Hu JM; Hsu CH; Chou YC; Shih YL; Lin YW
Genes Chromosomes Cancer; 2018 May; 57(5):268-277. PubMed ID: 29363224
[TBL] [Abstract][Full Text] [Related]
39. p16 Gene methylation in colorectal tumors: correlation with clinicopathological features and prognostic value.
Sanz-Casla MT; Maestro ML; Vidaurreta M; Maestro C; Arroyo M; Cerdán J
Dig Dis; 2005; 23(2):151-5. PubMed ID: 16352895
[TBL] [Abstract][Full Text] [Related]
40. Prediction of onset of remnant gastric cancer by promoter DNA methylation of
Kojima K; Minatani N; Ushiku H; Ishii S; Tanaka T; Yokoi K; Nishizawa N; Ooizumi Y; Igarashi K; Hosoda K; Moriya H; Mieno H; Watanabe M; Yamashita K
Oncotarget; 2019 Mar; 10(25):2423-2434. PubMed ID: 31069006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
